The growing interest of nephrologists in GLP-1 receptor agonists derives from numerous studies showing that not only they positively affect traditional cardiovascular risk factors, but also exert a protective effect on renal function regardless of their hypoglycemic effects, thus delaying the development and progression of diabetic nephropathy
glp-1(ar202) is a temperature sensitive gain of function allele, used to produce cells throughout the germline that are undergoing GLP-1 signaling
This classification means they do not require FDA approval for safety or efficacy before marketing, and manufacturers cannot legally claim to diagnose, treat, cure, or prevent disease
Promoting metabolism: At the cellular level, Meglutide activates relevant metabolic pathways in fat cells, liver cells, and skeletal muscle cells, enhancing lipolysis metabolism, stimulating the breakdown of triglycerides into free fatty acids, and transferring them to mitochondria for efficient oxidation and energy supply